Skip to content
Subscriber Only

Pacific Biosciences Raises $200 Million in U.S. IPO

Pacific Biosciences of California Inc. raised $200 million pricing its initial public offering at the midpoint of the forecast range in the latest sign that the U.S. IPO market is stabilizing. The shares advanced.

The developer of gene mapping technology sold 12.5 million shares at $16 each yesterday after offering them at $15 to $17 apiece, a filing with the Securities and Exchange Commission and data compiled by Bloomberg show. The Menlo Park, California-based company’s shares climbed 2.8 percent to $16.44 in Nasdaq Stock Market trading today.